Bionor Pharma News

3,24 +1,25% +0,04 €
18.06.18 Frankfurt | Orderbuch | Mehr Kurse »
WKN: 932314
ISIN: NO0003106700
US-Symbol: BNRPF
Typ: Aktie

Bionor Pharma News

  
23.08.16 Bionor H1 2016 Interim Financial Report GlobeNewswire
12.08.16 Bionor provides more details on the contemplated private placement GlobeNewswire
20.06.16 Bionor provides update on funding GlobeNewswire
13.06.16 Bionor provides an update on scientific collaborations GlobeNewswire
09.06.16 The peer-​reviewed and highly recognized journal The Lancet HIV has accepted the results of the REDUC Part B trial for publication GlobeNewswire
06.06.16 Minutes from the Extraordinary General Meeting 6 June 2016 GlobeNewswire
31.05.16 Update from the Board on clinical strategy and capital structure GlobeNewswire
11.05.16 Bionor Q1 2016 Interim Financial Report GlobeNewswire
23.02.16 The final assay in Bionor's REDUC trial for measuring latent HIV reservoir, Integrated HIV DNA, supports the Shock & Kill approach using Vacc-4x and romidepsin GlobeNewswire
12.02.16 Bionor Q4 and Full Year 2015 Interim Financial Report GlobeNewswire
21.12.15 Bionor announces that the HIV 'Shock & Kill' trial REDUC with Vacc-4x and romidepsin meets its primary endpoint by significantly reducing latent HIV reservoir and demonstrates control of viral loa GlobeNewswire
09.01.15 David Horn Solomon assumes the role as President and Chief Executive Officer of Bionor Pharma ASA GlobeNewswire
16.05.12 Bionor Pharma-​Aktie: anhaltend guter Newsflow - Global Biotech Investing Aktiencheck
22.02.12 Bionor Pharma Datenauswertung sorgt für gewaltigen Rückenwind - Global Biotech Investing Aktiencheck
15.03.10 Vacc-C5 to be prepared for phase I/II clinical trial Hugin
25.01.10 Thorleif Krarup proposed as new Chairman of Nutri Pharma ASA Hugin
25.01.10 PRIVATE PLACEMENT Hugin
23.01.10 Financial calendar 2010 Hugin
22.01.10 Notice for extraordinary shareholders meeting Hugin
22.01.10 Notice for extraordinary shareholders meeting Hugin
14.01.10 Voluntary offer from Nutri Pharma ASA to purchase shares in Bionor Immuno AS. Hugin
13.01.10 Mandatory notification of trade. Hugin
12.01.10 Nutri Pharma ASA to launch a voluntary offer for vaccine developer Bionor Immuno AS Hugin
12.01.10 Nutri Pharma ASA to launch a voluntary offer for vaccine developer Bionor Immuno AS Hugin
22.10.09 Nutri5® and Brain Health related to treatment of menopausal symptoms Hugin
21.04.09 European launch of Nutri5® Hugin

Newssuche